Peer-reviewed article

Is Poorly Assisted Psilocybin Treatment an Increasing Risk?

Schenberg EE, King F 4th, da Fonseca JE, Roseman L

The American journal of psychiatryJan 1, 2024Brazil21 citationsDOI: 10.1176/appi.ajp.20230664

Topics & conditions

Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.

PsilocybinDepression

Keywords

EthicsPharmacotherapyDepressive DisorderspsychotherapyMedication-assisted TreatmentResearch Design And MethodsDrug/psychotherapy Combination

View paper

Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.

Related research

ArticlePsilocybin

Association of Psilocybin Use in Adolescents with Major Depressive Episode

Shah K, Trivedi C, Kamrai D +2

Europe PMC2022

ArticlePsilocybin

Australia to prescribe MDMA and psilocybin for PTSD and depression in world first.

Haridy R

Europe PMC2023

ArticlePsilocybin

Cystathionine Gamma-Lyase Regulate Psilocybin Biosynthesis in <i>Gymnopilus dilepis</i> Mushroom via Amino Acid Metabolism Pathways.

Yao S, Wei C, Lin H +5

Europe PMC2022